{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:52:29Z","timestamp":1774353149153,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In primary care, elevated liver values often appear as incidental findings. As well considering the presenting symptoms, key factors in effective diagnosis are which liver values to include as indicators and when to refer patients for further diagnostics. It is also important that there is coordinated collaboration between GPs and specialists. There has hitherto been a lack of reliable findings on the status quo regarding the evaluation of (abnormally) elevated liver values in primary care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between 2017 and 2021, four written explorative surveys of GPs and gastroenterological specialists were conducted in various German states, aimed at taking stock of the current status of GP-based diagnostics of (abnormally) elevated liver values. In addition, interviews were conducted with 14 GPs and gastroenterological specialists. This review article discusses the overall findings of the series of studies in a condensed manner at a higher level. The article aims to derive starting points for optimising the diagnosis of liver cirrhosis in primary care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There are various challenges and problems associated with the evaluation of elevated liver values. For example, GPs draw on very different laboratory parameters, which are combined in different clusters. When elevated liver values are found, a majority of GPs prefer a controlled wait-and-see period, but often make use of direct referrals to specialists due to diagnostic uncertainties. GPs report interface problems with gastroenterological specialists, which are associated, among other things, with the preliminary evaluation that has been made and the timing of referral. Both GPs and specialists consider the introduction of an evidence-based diagnostic algorithm to be an important starting point for improving early detection and better coordination between healthcare levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Efforts should be made to contribute to greater professionalisation and standardisation of primary care diagnostics and to better structure the interaction with gastroenterological specialists. These include a wider range of training formats, the development of a validated diagnostic pathway and the mandating of a liver function test as part of the check-up. The development of a GP-based guideline for managing elevated liver values also seems advisable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-022-01714-x","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T23:02:39Z","timestamp":1651532559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of elevated liver values in primary care - a series of studies on the status quo of care in Germany with special reference to alcoholic liver disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Julian","family":"Wangler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"issue":"1","key":"1714_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MEG.0000000000000233","volume":"27","author":"S Radcke","year":"2015","unstructured":"Radcke S, Dillon JF, Murray AL. A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. Eur J Gastroenterol Hepatol. 2015;27(1):1\u20137. PMID: 25380394. https:\/\/doi.org\/10.1097\/MEG.0000000000000233.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"1714_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1055\/s-2008-1027157","volume":"46","author":"S Lobstein","year":"2008","unstructured":"Lobstein S, Kaiser T, Liebert U, et al. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a German cohort of orthopaedic surgery patients. Z Gastroenterol. 2008;46(5):415\u201320. PMID: 18461515. https:\/\/doi.org\/10.1055\/s-2008-1027157.","journal-title":"Z Gastroenterol"},{"key":"1714_CR3","doi-asserted-by":"publisher","first-page":"P5_30","DOI":"10.1055\/s-0030-1269736","volume":"49","author":"J Schattenberg","year":"2011","unstructured":"Schattenberg J, Wild P, Zeller T, et al. Prevalence of elevated GPT and gGT values and associated risk factors - a cross-sectional analysis of 5000 participants in the Gutenberg heart study. Z Gastroenterol. 2011;49:P5_30. https:\/\/doi.org\/10.1055\/s-0030-1269736.","journal-title":"Z Gastroenterol"},{"issue":"1","key":"1714_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.gastro.2007.10.024","volume":"134","author":"SE Baumeister","year":"2008","unstructured":"Baumeister SE, Volzke H, et al. Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology. 2008;134(1):85\u201394. PMID: 18005961. https:\/\/doi.org\/10.1053\/j.gastro.2007.10.024.","journal-title":"Gastroenterology"},{"issue":"3","key":"1714_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1055\/a-0965-9648","volume":"145","author":"V Keitel","year":"2020","unstructured":"Keitel V, vom Dahl S, H\u00e4ussinger D. Secondary causes of fatty liver disease \u2013 an update on pathogenesis, diagnosis and treatment strategies. Dtsch Med Wochenschr. 2020;145(3):140\u20135. PMID: 32018285. https:\/\/doi.org\/10.1055\/a-0965-9648.","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"1714_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","volume":"136","author":"CE Ruhl","year":"2009","unstructured":"Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009;136(2):477\u2013485.e11. PMID: 19100265. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.052.","journal-title":"Gastroenterology"},{"issue":"3","key":"1714_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/hep.22090","volume":"47","author":"HL Tae","year":"2008","unstructured":"Tae HL, Kim WR, Benson JT, Therneau TM, Melton LJ. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008;47(3):880\u20137. PMID: 18302294. https:\/\/doi.org\/10.1002\/hep.22090.","journal-title":"Hepatology"},{"issue":"3\u20134","key":"1714_CR8","first-page":"191","volume":"40","author":"M Fulks","year":"2008","unstructured":"Fulks M, Stout R, Dolan V. Using liver enzymes as screening tests to predict mortality risk. J Insur Med. 2008;40(3\u20134):191\u2013203 PMID: 19317327.","journal-title":"J Insur Med"},{"issue":"2","key":"1714_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/liv.12311","volume":"34","author":"E Koehler","year":"2014","unstructured":"Koehler E, Sanna D, Hansen B, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int. 2014;34(2):296\u2013304. PMID: 24219360. https:\/\/doi.org\/10.1111\/liv.12311.","journal-title":"Liver Int"},{"issue":"1","key":"1714_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ije\/dyt192","volume":"43","author":"S Kunutsor","year":"2014","unstructured":"Kunutsor S, Apekey T, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):187\u2013201. PMID: 24585856. https:\/\/doi.org\/10.1093\/ije\/dyt192.","journal-title":"Int J Epidemiol"},{"issue":"1086","key":"1714_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/postgradmedj-2015-133715","volume":"92","author":"S Agrawal","year":"2016","unstructured":"Agrawal S, Dhiman RK, Limdi JK. Evaluation of abnormal liver function tests. Postgrad Med J. 2016;92(1086):223\u201334. PMID: 26842972. https:\/\/doi.org\/10.1136\/postgradmedj-2015-133715.","journal-title":"Postgrad Med J"},{"issue":"4","key":"1714_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/gast.2002.36061","volume":"123","author":"R Green","year":"2002","unstructured":"Green R, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367\u201384. PMID: 12360498. https:\/\/doi.org\/10.1053\/gast.2002.36061.","journal-title":"Gastroenterology"},{"issue":"1","key":"1714_CR13","doi-asserted-by":"publisher","first-page":"205427041561130","DOI":"10.1177\/2054270415611309","volume":"7","author":"A Chadwick","year":"2016","unstructured":"Chadwick A, Marks M. Low yield of unselected testing in patients with acutely abnormal liver function tests. JRSM Open. 2016;7(1):2054270415611309. PMID: 26770816. https:\/\/doi.org\/10.1177\/2054270415611309.","journal-title":"JRSM Open"},{"key":"1714_CR14","unstructured":"Lawrence S, Friedman: approach to the patient with abnormal liver biochemical and function tests. Available from: URL: https:\/\/www.uptodate.com\/contents\/approach-to-the-patient-with-abnormal-liver-biochemical-and-function-tests [cited 30 Oct 2021]."},{"issue":"4","key":"1714_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-0032-1327255","volume":"138","author":"M Bahr","year":"2013","unstructured":"Bahr M. Analysing elevated liver values. Dtsch Med Wochenschr. 2013;138(4):131\u201348. https:\/\/doi.org\/10.1055\/s-0032-1327255.","journal-title":"Dtsch Med Wochenschr"},{"key":"1714_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/256426","volume":"256426","author":"SA Al-Busafi","year":"2013","unstructured":"Al-Busafi SA, Hilzenrat N. Mild Hypertransaminasemia in primary care. ISRN Hepatol. 2013;256426:1\u20136. PMID: 27335825. https:\/\/doi.org\/10.1155\/2013\/256426.","journal-title":"ISRN Hepatol"},{"issue":"22\u201323","key":"1714_CR17","first-page":"1104","volume":"113","author":"HW Zimmermann","year":"2016","unstructured":"Zimmermann HW, Tacke F, Kroy D, Trautwein C. Gastroenterology: elevated liver values - what now? Dtsch Arztebl Int. 2016;113(22\u201323):1104\u20138.","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"1714_CR18","first-page":"709","volume":"96","author":"RC Oh","year":"2017","unstructured":"Oh RC, Hustead TR, Ali SM, Pantsari MW. Mildly elevated liver transaminase levels: causes and evaluation. Am Fam Physician. 2017;96(11):709\u201315.","journal-title":"Am Fam Physician"},{"issue":"3","key":"1714_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s15006-017-9250-0","volume":"159","author":"P Stiefelhagen","year":"2017","unstructured":"Stiefelhagen P. How to clarify elevated liver values. MMW Fortschr Med. 2017;159(3):18. PMID: 28224545. https:\/\/doi.org\/10.1007\/s15006-017-9250-0.","journal-title":"MMW Fortschr Med"},{"issue":"1","key":"1714_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18\u201335. PMID: 27995906. https:\/\/doi.org\/10.1038\/ajg.2016.517.","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"1714_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1055\/a-0753-6021","volume":"144","author":"D Bettinger","year":"2019","unstructured":"Bettinger D, Thimme R. Clinical management of patients with new diagnosis of liver cirrhosis. Dtsch Med Wochenschr. 2019;144(18):1251\u20138. PMID: 31514215. https:\/\/doi.org\/10.1055\/a-0753-6021.","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"1714_CR22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","volume":"51","author":"P Jepsen","year":"2010","unstructured":"Jepsen P, Ott P, Andersen PK, S\u00f8rensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51(5):1675\u201382. PMID: 20186844. https:\/\/doi.org\/10.1002\/hep.23500.","journal-title":"Hepatology"},{"issue":"3","key":"1714_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58(3):593\u2013608. PMID: 23419824. https:\/\/doi.org\/10.1016\/j.jhep.2012.12.005.","journal-title":"J Hepatol"},{"issue":"1","key":"1714_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1055\/s-0028-1109980","volume":"48","author":"H Wedemeyer","year":"2010","unstructured":"Wedemeyer H, Hofmann WP, Lueth S, et al. ALT screening for chronic liver diseases: scrutinizing the evidence. Z Gastroenterol. 2010;48(1):46\u201355. PMID: 20072996. https:\/\/doi.org\/10.1055\/s-0028-1109980.","journal-title":"Z Gastroenterol"},{"issue":"6","key":"1714_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3238\/arztebl.2013.0085","volume":"110","author":"J Wiegand","year":"2013","unstructured":"Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int. 2013;110(6):85\u201391. PMID: 23451000. https:\/\/doi.org\/10.3238\/arztebl.2013.0085.","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"1714_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"JM Llovet","year":"2012","unstructured":"Llovet JM, Ducreux M, Lencioni R, et al. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908\u201343. PMID: 22424438. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.001.","journal-title":"J Hepatol"},{"issue":"3","key":"1714_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.23785","volume":"52","author":"T Chang","year":"2010","unstructured":"Chang T, Liaw Y, Wu S, et al. Long-term Entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52(3):886\u201393. PMID: 20683932. https:\/\/doi.org\/10.1002\/hep.23785.","journal-title":"Hepatology"},{"issue":"5","key":"1714_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/gutjnl-2012-302024","volume":"62","author":"R Zoutendijk","year":"2013","unstructured":"Zoutendijk R, Reijnders JGP, Zoulim F, et al. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. Gut. 2013;62(5):760\u20135. PMID: 22490523. https:\/\/doi.org\/10.1136\/gutjnl-2012-302024.","journal-title":"Gut."},{"issue":"3","key":"1714_CR29","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.21907","volume":"46","author":"G Garcia-Tsao","year":"2007","unstructured":"Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922\u201338. PMID: 17879356. https:\/\/doi.org\/10.1002\/hep.21907.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"1714_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1478-3231.2008.01938.x","volume":"29","author":"M Colombo","year":"2009","unstructured":"Colombo M. Screening and diagnosis of hepatocellular carcinoma. Liver Int. 2009;29(Suppl 1):143\u20137. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01938.x.","journal-title":"Liver Int"},{"issue":"6","key":"1714_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0043-122251","volume":"143","author":"M Jansky","year":"2018","unstructured":"Jansky M, Mattlinger C, Nguyen-Tat M, et al. Evaluation of abnormal liver chemistries in general practitioner care \u2013 the reality of primary Care in Germany. Dtsch Med Wochenschr. 2018;143(6):34\u201341. PMID: 29316587. https:\/\/doi.org\/10.1055\/s-0043-122251.","journal-title":"Dtsch Med Wochenschr"},{"key":"1714_CR32","doi-asserted-by":"publisher","unstructured":"Wangler J, Jansky M. Evaluation of abnormal liver chemistries in primary care \u2013 A survey on the prerequisites, procedure and challenges faced by general practitioners. Z Gastroenterol. 2020. https:\/\/doi.org\/10.1055\/a-1213-6491 Available at: https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/10.1055\/a-1213-6491. PMID: 32838434.","DOI":"10.1055\/a-1213-6491"},{"issue":"12","key":"1714_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3238\/zfa.2018.0494-0499","volume":"94","author":"M Jansky","year":"2018","unstructured":"Jansky M, Wangler J, Nguyen-Tat M, Arslanow A, Galle PR. Clarification of elevated liver values \u2013 how do gastroenterological specialists experience cooperation with family practitioners? Z Allg Med. 2018;94(12):494\u20139. https:\/\/doi.org\/10.3238\/zfa.2018.0494-0499.","journal-title":"Z Allg Med"},{"issue":"13\u201314","key":"1714_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10354-021-00855-5","volume":"171","author":"J Wangler","year":"2021","unstructured":"Wangler J, Claus S, Jansky M. Working relationship between primary and specialist care in analysing elevated liver values \u2013 a survey from the point of view of gastroenterologists. Wien Med Wochenschr. 2021;171(13\u201314):301\u20139. PMID: 34185218. https:\/\/doi.org\/10.1007\/s10354-021-00855-5.","journal-title":"Wien Med Wochenschr"},{"issue":"6","key":"1714_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1055\/a-1008-5848","volume":"145","author":"J Wangler","year":"2020","unstructured":"Wangler J, Jansky M. One and a half decades of disease management programs \u2013 status quo from the point of view of general practitioners. Dtsch Med Wochenschr. 2020;145(6):32\u201340. PMID: 31863449. https:\/\/doi.org\/10.1055\/a-1008-5848.","journal-title":"Dtsch Med Wochenschr"},{"key":"1714_CR36","unstructured":"Mayring P. Qualitative content analysis. Theoretical foundation, basic procedures and software solution. Available from: URL: https:\/\/nbn-resolving.de\/urn:nbn:de:0168-ssoar-395173 [cited 22 Mar 2022]."},{"issue":"6","key":"1714_CR37","doi-asserted-by":"publisher","first-page":"e003099","DOI":"10.1136\/bmjopen-2013-003099","volume":"3","author":"RJ Lilford","year":"2013","unstructured":"Lilford RJ, Bentham LM, Armstrong MJ, Neuberger J, Girling AJ. What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study. BMJ Open. 2013;3(6):e003099. PMID: 23794594. https:\/\/doi.org\/10.1136\/bmjopen-2013-003099.","journal-title":"BMJ Open"},{"issue":"4","key":"1714_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.14218\/JCTH.2017.00027","volume":"5","author":"M Malakouti","year":"2017","unstructured":"Malakouti M, Kataria A, Ali SK, Schenker S. Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do? J Clin Transl Hepatol. 2017;5(4):394\u2013403. PMID: 29226106. https:\/\/doi.org\/10.14218\/JCTH.2017.00027.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"1714_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367\u201379. PMID: 15684121. https:\/\/doi.org\/10.1503\/cmaj.1040752.","journal-title":"CMAJ"},{"issue":"1","key":"1714_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","volume":"67","author":"PN Newsome","year":"2018","unstructured":"Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6\u201319. PMID: 29122851. https:\/\/doi.org\/10.1136\/gutjnl-2017-314924.","journal-title":"Gut"},{"issue":"5","key":"1714_CR41","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","volume":"98","author":"JM Clark","year":"2003","unstructured":"Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960\u20137. PMID: 12809815. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07486.x.","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"1714_CR42","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1055\/s-0042-100041","volume":"141","author":"A Holstege","year":"2016","unstructured":"Holstege A. Elevated liver enzymes. Dtsch Med Wochenschr. 2016;141(22):1640\u20136. PMID: 27824421. https:\/\/doi.org\/10.1055\/s-0042-100041.","journal-title":"Dtsch Med Wochenschr"},{"issue":"26","key":"1714_CR43","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","volume":"20","author":"N Toshikuni","year":"2014","unstructured":"Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8393\u2013406. PMID: 25024597. https:\/\/doi.org\/10.3748\/wjg.v20.i26.8393.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01714-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-022-01714-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01714-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T23:02:48Z","timestamp":1651532568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-022-01714-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1186\/s12875-022-01714-x","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"30 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations.Since this is an overview article on the status of the topic under discussion, the Ethics Commission of the State of Rhineland-Palatinate, Germany, informed us that approval by an ethics committee was not necessary.Written informed consent for participation was obtained from all participants before the start of the sub-studies [\u2013]. The respondents received information about the aim and purpose of the respective study and were informed that it was an anonymous survey in accordance with the existing data protection standards. Furthermore, it was made clear that the data will only be used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}